Study of a Booster Dose of IMOJEV® One Year After Primary Immunization in Healthy Children in South Korea

NCT01900444 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

119

Enrollment

INDUSTRY

Sponsor class

Conditions

Japanese Encephalitis

Interventions

BIOLOGICAL: IMOJEV

Sponsor

Sanofi Pasteur, a Sanofi Company